Literature DB >> 35034254

Circ_0025039 acts an oncogenic role in the progression of non-small cell lung cancer through miR-636-dependent regulation of CORO1C.

Lei Wang1, Cimei Zeng1, Zhongren Chen1, Jianxu Qi1, Sini Huang1, Haimei Liang1, Shiren Huang1, Zongxing Ou2.   

Abstract

Non-small cell lung cancer remains the leading cause of cancer-related death worldwide. Circular RNA plays vital roles in NSCLC progression. This study is designed to reveal the role of circ_0025039 in NSCLC cell malignancy. The RNA expression of circ_0025039, microRNA-636 (miR-636), and coronin 1C was detected by quantitative real-time polymerase chain reaction. Protein expression was checked by Western blot analysis or immunohistochemistry assay. Cell proliferation, migration, invasion, tube formation ability, sphere formation capacity, and apoptosis were investigated by cell counting kit-8, 5-Ethynyl-29-deoxyuridine, transwell assay, tube formation assay, sphere formation assay, and flow cytometry analysis, respectively. Mouse model assay was conducted to reveal the effect of circ_0025039 silencing on tumor formation in vivo. The interaction between miR-636 and circ_0025039 or CORO1C was identified through dual-luciferase reporter and RNA pull-down assays. The expression of circ_0025039 and CORO1C was significantly increased, while miR-636 was decreased in NSCLC tissues and cells compared with controls. Circ_0025039 depletion repressed NSCLC cell proliferation, migration, invasion, tube-forming capacity, and sphere formation ability, but induced cell apoptosis. The neoplasm formation was repressed after circ_0025039 silencing. Additionally, circ_0025039 acted as a sponge for miR-636, which was found to target CORO1C. Importantly, the contribution of circ_0025039 to NSCLC progression was mediated by miR-636/CORO1C axis. Circ_0025039 silencing repressed NSCLC malignant progression by reducing CORO1C expression through miR-636, showing the possibility of circ_0025039 as a therapeutic target for NSCLC.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CORO1C; Circ_0025039; NSCLC; miR-636

Mesh:

Substances:

Year:  2022        PMID: 35034254     DOI: 10.1007/s11010-021-04320-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  34 in total

1.  Circ_0000376 enhances the proliferation, metastasis, and chemoresistance of NSCLC cells via repressing miR-384.

Authors:  Hui Sun; Yi Chen; Yue-Yu Fang; Ting-Yun Cui; Xue Qiao; Chun-Yu Jiang; Zhi-Bin Lu
Journal:  Cancer Biomark       Date:  2020       Impact factor: 4.388

2.  Circular RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically Expressed.

Authors:  Agnieszka Rybak-Wolf; Christin Stottmeister; Petar Glažar; Marvin Jens; Natalia Pino; Sebastian Giusti; Mor Hanan; Mikaela Behm; Osnat Bartok; Reut Ashwal-Fluss; Margareta Herzog; Luisa Schreyer; Panagiotis Papavasileiou; Andranik Ivanov; Marie Öhman; Damian Refojo; Sebastian Kadener; Nikolaus Rajewsky
Journal:  Mol Cell       Date:  2015-04-23       Impact factor: 17.970

3.  Circular RNA hsa_circ_0014130 Inhibits Apoptosis in Non-Small Cell Lung Cancer by Sponging miR-136-5p and Upregulating BCL2.

Authors:  Ying Geng; Yongxia Bao; Wei Zhang; Lili Deng; Dongju Su; Hongyan Zheng
Journal:  Mol Cancer Res       Date:  2020-02-14       Impact factor: 5.852

4.  Upregulation of Circular RNA VPS13C-has-circ-001567 Promotes Ovarian Cancer Cell Proliferation and Invasion.

Authors:  Liuping Bao; Jianxin Zhong; Lijuan Pang
Journal:  Cancer Biother Radiopharm       Date:  2018-10-30       Impact factor: 3.099

5.  The Landscape of Circular RNA in Cancer.

Authors:  Josh N Vo; Marcin Cieslik; Yajia Zhang; Sudhanshu Shukla; Lanbo Xiao; Yuping Zhang; Yi-Mi Wu; Saravana M Dhanasekaran; Carl G Engelke; Xuhong Cao; Dan R Robinson; Alexey I Nesvizhskii; Arul M Chinnaiyan
Journal:  Cell       Date:  2019-02-07       Impact factor: 41.582

6.  Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer.

Authors:  Longqiang Wang; Xin Tong; Zhengyu Zhou; Shengjie Wang; Zhe Lei; Tianze Zhang; Zeyi Liu; Yuanyuan Zeng; Chang Li; Jun Zhao; Zhiyue Su; Cuijuan Zhang; Xia Liu; Guangquan Xu; Hong-Tao Zhang
Journal:  Mol Cancer       Date:  2018-09-27       Impact factor: 27.401

7.  Ectopic expression of ROR1 prevents cochlear hair cell loss in guinea pigs with noise-induced hearing loss.

Authors:  Jun Zhang; Wei Zhang; Qinliang Zhang
Journal:  J Cell Mol Med       Date:  2020-07-07       Impact factor: 5.310

8.  microRNA-605 promotes cell proliferation, migration and invasion in non-small cell lung cancer by directly targeting LATS2.

Authors:  Ying Ye; Juhua Zhuang; Guoyu Wang; Saifei He; Jing Ni; Wei Xia; Jiening Wang
Journal:  Exp Ther Med       Date:  2017-06-01       Impact factor: 2.751

9.  CircPIP5K1A facilitates gastric cancer progression via miR-376c-3p/ZNF146 axis.

Authors:  Yan Ma; Xiliang Cong; Yiyun Zhang; Xin Yin; Ziyu Zhu; Yingwei Xue
Journal:  Cancer Cell Int       Date:  2020-03-14       Impact factor: 5.722

10.  Bupivacaine suppresses the progression of gastric cancer through regulating circ_0000376/miR-145-5p axis.

Authors:  Changqiao Ju; Jia Zhou; Hui Miao; Xin Chen; Qingyu Zhang
Journal:  BMC Anesthesiol       Date:  2020-10-30       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.